For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230630:nRSd5401Ea&default-theme=true
RNS Number : 5401E Tintra PLC 30 June 2023
30 June 2023
TINTRA PLC
("Tintra", the "Group" or the "Company")
Directorate & Management Change
Following the announcement on 9 March 2023, the board of directors (the
"Board") of Tintra, the fast-growth Deep Tech & Banking business, are
pleased to confirm the transition of Dr Vanessa Neumann to Chair of Strategic
Initiatives for Latin America and the Caribbean is complete.
As advised in the earlier announcement Dr Neumann will now give her full
attention to her vital role of developing the Company's strategy in the
western hemisphere and as such has stood down from the board as a
Non-Executive Director. It is expected that Dr Neumann will become a director
of the Company's Puerto Rico business in due course.
With exciting initiatives already developing in the region the Board is
incredibly grateful for the work past and future and wishes to greatly thank
Vanessa for her expertise, guidance and enthusiasm and we look forward to the
future.
For further information, contact:
Tintra PLC 020 3795 0421
(Communications Head)
Hannah Haffield
h.haffield@tintra.com
Website www.tintra.com
Allenby Capital Limited 020 3328 5656
(Nomad, Financial Adviser & Broker)
John Depasquale / Nick Harriss / Vivek Bhardwaj
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAURVBROAUNORR